Text Size
18 studies found for:    HLA-DQA1

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Completed HLA-DQ2-gliadin Tetramer for Diagnosis of Celiac Disease
Conditions: Celiac Disease;   Gluten
Intervention: Dietary Supplement: Gluten challenge.
2 Active, not recruiting Alpha-Type 1 Dendritic Cell (DC)-Based Vaccines Loaded With Allogeneic Prostate Cell Lines in Combination With Androgen Ablation in Patients With Prostate Cancer
Condition: Prostate Cancer
Interventions: Biological: androgen ablation + dendritic cell vaccine;   Biological: androgen ablation plus dendritic cell vaccine
3 Completed Immunogenicity and Safety of a Novel Adjuvanted HBV Vaccine in Healthy Volunteers Positive for the HLA-DQ2 Genotype
Condition: Hepatitis B
Interventions: Biological: HBV-MPL vaccine 208129;   Biological: Engerix™-B
4 Completed Clinical Relevance of Typing HLA-DR7-DQ2
Conditions: Celiac Disease Patients Following Recommendations of ESPGHAN;   HLA-DQ2 Typing Include HLA-DR7-DQ2 Haplotypes
Intervention: Other: There is not any intervention
5 Completed Gluten Intolerance in Patients With Diarrhea Predominant Irritable Bowel Syndrome
Conditions: Diarrhea;   Diarrhea Predominant Irritable Bowel Syndrome
Interventions: Other: Gluten free diet;   Other: Gluten rich diet
6 Unknown † Vaccine Therapy in Treating Patients Who Are Undergoing Surgery for Ductal Carcinoma In Situ of the Breast
Condition: Breast Cancer
Interventions: Biological: therapeutic autologous dendritic cells;   Procedure: conventional surgery;   Procedure: neoadjuvant therapy
7 Active, not recruiting Vaccination-Dendritic Cells With Peptides for Recurrent Malignant Gliomas
Condition: Malignant Glioma
Interventions: Biological: Dendritic vaccine pulsed with multiple peptides;   Biological: The first booster vaccine phase:;   Biological: The second booster vaccine phase:
8 Unknown † Vaccine Therapy in Treating Patients With Ductal Carcinoma In Situ of the Breast
Condition: Breast Cancer
Interventions: Biological: HER-2/neu peptide vaccine;   Biological: therapeutic autologous dendritic cells
9 Not yet recruiting Dendritic Cell Vaccines + Dasatinib for Metastatic Melanoma
Condition: Metastatic Melanoma
Interventions: Biological: DC vaccine;   Drug: Dasatinib
10 Completed Safety Study of Nexvax2 in Subjects With Coeliac Disease
Conditions: Coeliac Disease;   Celiac Disease
Interventions: Biological: 9 micrograms Nexvax2;   Biological: 30 micrograms Nexvax2;   Biological: 90 micrograms Nexvax2;   Biological: 60 micrograms Nexvax2;   Biological: Up to 900 micrograms Nexvax2;   Other: Placebo
11 Completed The Effect of Adalimumab (Humira) on Vascular Abnormalities in Rheumatoid Arthritis. A Pilot Study.
Condition: Rheumatoid Arthritis
Intervention: Drug: Adalimumab
12 Recruiting Study to Test Sensitivity and Specificity of Passive Wave Pressure Device in Determining Ischemic Stroke
Condition: Ischemic Stroke
Intervention: Device: Nautilus NeuroWaveTM System
13 Completed Comparison of Anti-HIV Drug Combinations to Prevent Mother-to-Child Transmission of HIV
Condition: HIV Infections
Interventions: Drug: Abacavir sulfate, lamivudine, and zidovudine;   Drug: Lamivudine/zidovudine;   Drug: Lopinavir/ritonavir
14 Completed AMD3100 to Mobilize Stem Cells for Donation
Conditions: Healthy;   Blood Component Removal
Intervention: Drug: AMD3100
15 Completed Discharge Coordinator Intervention in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Other: Coordinated discharge;   Other: Control
16 Recruiting Non-Significant Risk Study Comparing the Nautilus NeuroWaveTM to Transcranial Doppler as an Aid to Diagnosing Vasospasm
Condition: Cerebral Vasospasm
Intervention: Device: Nautilus NeuroWaveTM System
17 Recruiting Safety of Labeled Dendritic Cell (DC) Vaccines and Feasibility of Tracking by Magnetic Resonance Imaging (MRI)
Conditions: Colorectal Neoplasms;   Colorectal Cancer;   Colorectal Carcinoma;   Colorectal Tumors;   Neoplasms, Colorectal
Intervention: Biological: DC Vaccine
18 Active, not recruiting Immune Response in Patients Who Have Undergone Vaccine Therapy for Stage III or Stage IV Breast Cancer That Overexpresses HER2
Condition: Breast Cancer
Interventions: Biological: HER-2/neu intracellular domain protein;   Other: flow cytometry;   Other: immunohistochemistry staining method;   Procedure: biopsy;   Other: Sterile water placement
To Top

† Indicates status has not been verified in more than two years